Palantir Technologies Inc. broke records once again with its third-quarter earnings as the company’s artificial-intelligence ...
On Monday, major U.S. indexes showed mixed performance — the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, ...
Phio Pharmaceuticals shares were higher after the company reported positive pathology results for its Phase 1b Intasyl PH-762 trial. The stock was 32% higher, at $2.72. Shares are up 55% year to date.
18hOpinion
Big Week For Palantir And Robinhood
Both Robinhood Markets, Inc. (NASDAQ: HOOD) and Palantir Technologies Inc. (NASDAQ: PLTR) head into earnings with strong year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback